ArticleScientific reports2026
Predicting nicotine emissions and plasma nicotine boost in E-cigarette users using machine learning.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Assessing the Effect of Nicotine Reduction on ENDS User's Addiction and Exposures
The Effect of Menthol on ENDS Users' Dependence, Respiratory, and Toxicants Emission Outcomes.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
As e-cigarette use continues to rise globally, the need for reliable and scalable methods to quantify nicotine exposure in e-cigarette users has become more crucial. This study aims to develop supervised machine learning (ML) models that predict nicotine emission and plasma nicotine boost based on puff topography, personal and device characteristics, and e-liquid consumption. This study analyzed 259 measurements from e-cigarette users aged 21-35 years by combining human puff topography data with laboratory toxicant emission tests generated through validated playback procedures. Puffing behavior was recorded during ad libitum vaping sessions and replicated with a puffing robot (playback) to measure nicotine emissions. Plasma nicotine levels were determined via liquid chromatography-mass spectrometry. Six supervised regression models, including ordinary least squares, lasso, random forest, XGBoost, support vector regression, and neural networks, were trained to predict nicotine emissions and plasma nicotine boost from puffing parameters. The models were evaluated using an 80/20 train, test split with bootstrap resampling over 200 iterations, with performance metrics assessed by R², RMSE, and MAE. Among the ML methods evaluated, XGBoost consistently demonstrated the best performance (highest R², minimal RMSE, and MAE) for predicting both nicotine emissions and plasma nicotine boost. For nicotine emission prediction, XGBoost achieved the highest accuracy using either puff number (R² = 0.778 ± 0.153) or liquid consumption (R² = 0.747 ± 0.149) in combination with average puff duration and device characteristics (nicotine concentration and device). Using these emission estimates together with individual characteristics (age, sex, height, and weight), XGBoost-based plasma nicotine boost models showed the best explanatory performances for both puff-based (R² = 0.613 ± 0.174) and liquid-consumption-based (R² = 0.699 ± 0.168) predictors. This study shows that ML methods can effectively estimate nicotine emissions and plasma nicotine boost exposure directly from puffing behavior and device features. These models can support product regulation, assess addiction risk, and facilitate population-level surveillance.Trial registration: ClinicalTrials.gov (NCT05205382, NCT05338801).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.